Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep217 | Bone & Osteoporosis | ECE2017

Clinical manifestations and treatment approach in osteogenesis imperfecta

Tampouratzi Dimitra , Kalaitzidou Styliani , Sapera Aggeliki , Kotis Michalis , Kanouta Fotini , Triantafillou Eleni , Kyrimis Taxiarchis , Papadakis Georgios , Drakopoulou Anna , Kaltzidou Victoria , Tertipi Athanasia

Objectives: Osteogenesis imperfecta (OI) is a group of genetic disorders that mainly affects the bones. The underlying mechanism is usually a disorder of connective tissue due to lack of type I collagen. Usually, the disease is due to mutations in the COL1A1 or COL1A2 genes. The disease is inherited in an autosomal dominant manner or occurs via a de novo mutation. There are eight types of the disease. Type I is the most common and the least sever type and is due to mutation in...

ea0041ep1106 | Thyroid cancer | ECE2016

Biochemical effects of levothyroxine withdrawal in patients with differentiated thyroid cancer

Papadakis Georgios , Kalaitzidou Styliani , Triantafillou Eleni , Kakava Kassiani , Drosou Aspasia , Sapera Aggeliki , Dogkas Nikolaos , Pappa Theodora , Kaltzidou Victoria , Villiotou Vassiliki , Tertipi Athanasia

Background: Many patients with differentiated thyroid cancer (DTC) are treated with radiodine (I-131) after thyroidectomy, while they are hypothyroid and all are submitted to withdrawal of LT4 periodically for the evaluation of their disease. Among the tests used for follow-up is serum thyroglobulin (Tg) as a tumor marker, and occasionally, total body scan with I-131. Maximal sensitivity of the aforementioned tests is established in the hypothyroid state, under elevated thyrot...

ea0041ep1123 | Thyroid cancer | ECE2016

Analysis of BRAF and RAS genetic alterations in thyroid cancer in the Greek population

Kostoglou-Athanassiou Ifigenia , Argyropoulou Marilena , Karanatsiou Pagona , Papoutsidakis Georgios , Papadopoulou Alexandra , Loukou Kalliopi , Manolakelli Aikaterini , Synadaki Eleni , Vilaras George , Karameris Andreas , Liadaki Kalliopi

Introduction: Thyroid cancer is one of the most common malignancies of the endocrine system and displays a variety of histological patterns. The understanding of the molecular pathogenesis and the identification of molecular markers which will be used for diagnosis and prognosis is of high clinical significance. The most common molecular alterations include BRAF and RAS point mutations and RET/PTC and PAX8/PPARγ rearrangements. The pres...

ea0041ep1129 | Thyroid cancer | ECE2016

The diagnostic value of FNAB for early diagnosis of thyroid cancer: a Greek center experience

Triantafillou Eleni , Papadakis Georgios , Manitarou Paraskevi , Panagiotidi Evgenia , Kanouta Fotini , Drosou Aspasia , Kaldrymidis Philippos , Kaltzidou Victoria , Tsouma Eleni , Alexiadou Anastasia , Plyta Styliani , Tertipi Athanasia

Introduction: Fine needle aspiration biopsy (FNAB) is the initial investigation of choice for thyroid nodules.Methods: A total of 563 patients (106 males/457 females) underwent FNAB for the same number of thyroid nodules. Their mean age was 56.1±14.1 years. We correlated the demographic profile (age and gender) and sonographic features of these nodules with the FNAB outcome. The Bethesda system for reporting thyroid cytopathology was used.<p cla...

ea0059p170 | Obesity &amp; metabolism | SFEBES2018

Effects of visfatin on brown adipose tissue energy regulation

Dimitriadis Georgios K , Adya Raghu , Tan Bee K , Jones Terence A , Menon Vinod S , Ramanjaneya Manjunath , Kaltsas Gregory , Miras Alexander D , Randeva Harpal S

The role of brown adipose tissue (BAT) in pathological states of energy homeostasis and impaired adipocyte function, such as obesity has been a major area of research interest in recent years. Herein, we sought to determine the direct effects of adipokines, visfatin and leptin on BAT thermogenesis. The effects of mouse recombinant visfatin, nicotinamide mononucleotide (NMN) and leptin with or without FK866 were studied on differentiated T37i cells. Treated cells were analyzed ...

ea0037ep728 | Pituitary: clinical | ECE2015

Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogues: a meta-analysis

Efstathiadou Zoe A , Bargiota Alexandra , Chrisoulidou Alexandra , Kanakis Georgios , Papanastasiou Lamprini , Theodoropoulou Anastasia , Tigas Stylianos K , Vassiliadi Dimitra , Alevizaki Maria , Tsagarakis Stylianos

Objective: Somatic mutations in the GNAS1 gene, which encodes the alpha-subunit of G stimulatory proteins (gsp), are frequently detected in somatotroph pituitary tumors and have been associated to specific clinical-smaller and less invasive tumors occurring in older patients- and histopathological-densely granulated adenomas- characteristics. However, the question whether the presence of a somatic gsp mutation affects the response to somatostatin analogue treatment remains unr...

ea0035p1054 | Thyroid (non-cancer) | ECE2014

Steroid treatment in patients with active moderate-to-severe Graves orbitopathy

Tsirouki Theodora , Giotaki Zoi , Rizoulis Andreas , Tigas Stelios , Asproudis Ioannis , Tsatsoulis Agathocles , Kapsalaki Eftychia , Tsironi Evaggelia , Koukoulis Georgios N , Bargiota Alexandra

Background: Although IV steroids are the treatment of choice for moderate-to-severe graves orbitopathy (M-S GO), the most efficacious regimen is not yet defined. Cases not responding or relapsing after steroid treatment (STx) are not uncommon and STx can cause serious adverse events. The aim of the present study is to define the steroid regimen which balances between efficacy and damage, using stir-sequence orbital-MRI (SsMRIo) as an additional objective tool for the evaluatio...

ea0070oc6.3 | Hot Topics (including COVID-19 | ECE2020

Expression of estrogen-related receptors and epidermal growth factor receptor in normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

Parianos Christos , Kyriakopoulos Georgios , Nasiri-Ansari Narjes , Karapanagioti Angeliki , Angelousi Anna , Aggeli Chrysanthi , Zografos Giorgos , Choreftaki Theodosia , Kounadi Theodora , Randeva Harpal , Kaltsas Gregory , Papavassiliou Athanasios G , Kassi Evanthia

Introduction: The majority of adrenal neoplasms are benign while adrenocortical carcinomas (ACC) are rare with poor prognosis. Previous studies indicated that estrogens play important role in the etiology and progression of adrenocortical tumors. Estrogens exert genomic activities trough the estrogen-receptor (ER) subtypes α and β, while the non-genomic effects are mediated by membrane-bound-G-protein-coupled-ER-30 (GPR30). Although estrogens induce cancer cell ...

ea0070aep98 | Adrenal and Cardiovascular Endocrinology | ECE2020

Expression ofestrogen-related receptors andepidermal growth factor receptorin normal adrenal cortex and adrenocortical tumors: A possible role of GPR30 and EGFR in adrenocortical malignancy

Parianos Christos , Kyriakopoulos Georgios , Nasiri-Ansari Narjes , Karapanagioti Angeliki , Angelousi Anna , Aggeli Chrysanthi , Zografos Giorgos , Choreftaki Theodosia , Kounadi Theodora , Randeva Harpal , Kaltsas Gregory , Papavassiliou Athanasios G , Kassi Evanthia

Introduction: The majority of adrenal neoplasms are benign while adrenocortical carcinomas (ACC) are rare with poor prognosis. Previous studies indicated that estrogens play important role in the etiology and progression of adrenocortical tumors. Estrogens exert genomic activities trough the estrogen-receptor (ER) subtypes α and β, while the non-genomic effects are mediated by membrane-bound-G-protein-coupled-ER-30 (GPR30). Although estrogens induce cancer cell ...

ea0070aep374 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Liraglutide downregulates the expression of miRNA-424 in patients with obesity

Dimitriadis Georgios K , Dimitri Federica , Bate Danielle , Leca Bianca , Davasgaium Allan , Tripathi Gyanendra , Miras Alexander D , Rubino Francesco , Christian Mark , Randeva Harpal S

Aims: Liraglutide 3 mg once daily is an approved, prescription injectable Glucagon Like Peptide-1 receptor agonist that, when used with a low-calorie diet and increased physical activity, can reduce excess weight in patients with obesity. MiRNAs are small non-coding single stranded RNAs that regulate gene expression post-transcriptionally by inhibiting their mRNA target translation into proteins. MiRNAs can be secreted in the blood stream and affect the molecular pathways...